L2 Asset Management’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.36M Sell
2,911
-2,175
-43% -$914K 0.14% 141
2026
Q1
$1.92M Buy
5,086
+2,435
+92% +$1.04M 0.18% 106
2025
Q4
$1.13M Buy
2,651
+1,225
+86% +$533K 0.15% 126
2025
Q3
$639K Buy
1,426
+96
+7% +$43.5K 0.09% 183
2025
Q2
$647K Buy
1,330
+327
+33% +$186K 0.11% 165
2025
Q1
$617K Buy
1,003
+582
+138% +$331K 0.13% 129
2024
Q4
$223K Sell
421
-4
-0.9% -$2.25K 0.05% 227
2024
Q3
$255K Buy
425
+5
+1% +$2.83K 0.07% 189
2024
Q2
$228K Buy
420
+26
+7% +$14.9K 0.07% 192
2024
Q1
$253K Buy
394
+25
+7% +$15.2K 0.08% 177
2023
Q4
$216K Buy
+369
New +$206K 0.09% 165

Other funds holding CHE

L2 Asset Management's CHE Position: Q2 2026 in Review

L2 Asset Management reduced its Chemed (CHE) stake by 43% in Q2 2026, selling an estimated $914K and leaving 2,911 shares worth $1.36M. The position accounts for 0.14% of the portfolio, ranked #141.

L2 Asset Management first reported a position in CHE in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.92M in Q1 2026. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • L2 Asset Management held 2,911 shares of Chemed worth $1.36M as of Q2 2026.
  • L2 Asset Management sold 2,175 Chemed shares in Q2 2026, an estimated $914K.
  • Chemed made up 0.14% of L2 Asset Management's portfolio in Q2 2026, its #141 holding.
  • L2 Asset Management first reported a position in Chemed in Q4 2023 and has held it in 11 quarters since.
  • L2 Asset Management's Chemed position peaked at $1.92M in Q1 2026.
  • 530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on L2 Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.